Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
Titel:
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
Auteur:
Khoo, Saye H FitzGerald, Richard Saunders, Geoffrey Middleton, Calley Ahmad, Shazaad Edwards, Christopher J Hadjiyiannakis, Dennis Walker, Lauren Lyon, Rebecca Shaw, Victoria Mozgunov, Pavel Periselneris, Jimstan Woods, Christie Bullock, Katie Hale, Colin Reynolds, Helen Downs, Nichola Ewings, Sean Buadi, Amanda Cameron, David Edwards, Thomas Knox, Emma Donovan-Banfield, I'ah Greenhalf, William Chiong, Justin Lavelle-Langham, Lara Jacobs, Michael Northey, Josh Painter, Wendy Holman, Wayne Lalloo, David G Tetlow, Michelle Hiscox, Julian A Jaki, Thomas Fletcher, Thomas Griffiths, Gareth
Verschenen in:
The lancet infectious diseases
Paginering:
Jaargang 23 () nr. 2 pagina's 183-195
Jaar:
2023
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license